产品资料

Dasatinib, Free Base **

如果您对该产品感兴趣的话,可以
产品名称: Dasatinib, Free Base **
产品型号: LC D-3307
产品展商: 原装进口
产品文档: 无相关文档

简单介绍

Dasatinib, Free Base **


Dasatinib, Free Base **  的详细介绍
Dasatinib, Free Base **

产品名称:Dasatinib, Free Base
产品货号:LC  D-3307
产品规格:10 G
Small molecule inhibitor of both the SRC and BCR/ABL tyrosine kinases, with IC50's for the isolated kinases of 0.55 and 3.0 nM, respectively.  Lombardo, L.J., et al.  "Discovery of N-(2-chloro-6-methylphneyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino) thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in pre-clinical assays."  J. Med. Chem. 47:  6658-6661 (2004).
Dasatinib also inhibits Lyn (IC50 = 8.5 nM) and Src (IC50 = 3.0 nM) kinase activities in vitro using 0.1 mg/mL poly (Glu4-Tyr) as the substrate.  Nam, S., et al.  "Action of the Src Family Kinase Inhibitor, Dasatinib (BMS-354825), on Human Prostate Cancer Cells."  Cancer Res. 65:  9185-9189 (2005).
Dasatinib has greater potency than imatinib mesylate and has activity against the majority of kinase mutations in imatinib-resistant chronic myeloid leukemia.  Copland, M., et al.  "Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction."  Blood 107:  4532-4539 (2006).
Dasatinib and nilotinib are respectively 325-fold (IC50:  0.6 versus 280 nM) and 20-fold (IC50:  15 versus 280 nM) more potent than imatinib against cells expressing wild-type Bcr-Abl.  Similar improvements are also seen in all imatinib-resistant mutants tested, with the exception of T315I.  Both inhibitors have activity against imatinib-refractory chronic myelogenous leukemia.  O'Hare, T., et al.  "In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants."  Cancer Res. 65:  4500-4505 (2005).
Dasatinib is the active ingredient in the drug sold under the trade name Sprycel®.  This drug has been approved in at least one country for use in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia and chronic myelogenous leukemia.  It is also being tested for use in metastatic melanoma.  NOTE:  The dasatinib sold by LC Laboratories is NOT Sprycel®, and is NOT for human use.
Storage:  Store at or below -20 ºC.  Solubility:  Soluble in DMSO at 200 mg/mL; very poorly soluble in ethanol; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10 µM; buffers, serum, or other additives may increase or decrease the aqueous solubility.  Disposal:  A

 

产品留言
标题
联系人
联系电话
内容
验证码
点击换一张
注:1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!
使用指南 付款方式 客户关怀 **与保密 法律帮助 服务条款 监察中心信箱
分享到:

沪公网安备 31011002002623号